Literature DB >> 19805366

BG1 has a major role in MHC-linked resistance to malignant lymphoma in the chicken.

Ronald M Goto1, Yujun Wang, Robert L Taylor, Patricia S Wakenell, Kazuyoshi Hosomichi, Takashi Shiina, Craig S Blackmore, W Elwood Briles, Marcia M Miller.   

Abstract

Pathogen selection is postulated to drive MHC allelic diversity at loci for antigen presentation. However, readily apparent MHC infectious disease associations are rare in most species. The strong link between MHC-B haplotype and the occurrence of virally induced tumors in the chicken provides a means for defining the relationship between pathogen selection and MHC polymorphism. Here, we verified a significant difference in resistance to gallid herpesvirus-2 (GaHV-2)-induced lymphomas (Marek's disease) conferred by two closely-related recombinant MHC-B haplotypes. We mapped the crossover breakpoints that distinguish these haplotypes to the highly polymorphic BG1 locus. BG1 encodes an Ig-superfamily type I transmembrane receptor-like protein that contains an immunoreceptor tyrosine-based inhibition motif (ITIM), which undergoes phosphorylation and is recognized by Src homology 2 domain-containing protein tyrosine phosphatase (SHP-2). The recombinant haplotypes are identical, except for differences within the BG1 3'-untranslated region (3'-UTR). The 3'-UTR of the BG1 allele associated with increased lymphoma contains a 225-bp insert of retroviral origin and showed greater inhibition of luciferase reporter gene translation compared to the other allele. These findings suggest that BG1 could affect the outcome of GaHV-2 infection through modulation of the lymphoid cell responsiveness to infection, a condition that is critical for GaHV-2 replication and in which the MHC-B haplotype has been previously implicated. This work provides a mechanism by which MHC-B region genetics contributes to the incidence of GaHV-2-induced malignant lymphoma in the chicken and invites consideration of the possibility that similar mechanisms might affect the incidence of lymphomas associated with other oncogenic viral infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19805366      PMCID: PMC2757851          DOI: 10.1073/pnas.0906776106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Peptide motifs of the single dominantly expressed class I molecule explain the striking MHC-determined response to Rous sarcoma virus in chickens.

Authors:  Hans-Joachim Wallny; David Avila; Lawrence G Hunt; Timothy J Powell; Patricia Riegert; Jan Salomonsen; Karsten Skjødt; Olli Vainio; Francis Vilbois; Michael V Wiles; Jim Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

2.  Immune response versus susceptibility to Marek's disease.

Authors:  B W Calnek; D F Adene; K A Schat; H Abplanalp
Journal:  Poult Sci       Date:  1989-01       Impact factor: 3.352

3.  Influence of age at exposure on the pathogenesis of Marek's disease.

Authors:  B W Calnek
Journal:  J Natl Cancer Inst       Date:  1973-09       Impact factor: 13.506

4.  Response of six major histocompatibility (B) complex recombinant haplotypes to Rous sarcomas.

Authors:  E C White; W E Briles; R W Briles; R L Taylor
Journal:  Poult Sci       Date:  1994-06       Impact factor: 3.352

5.  Influence of oncogenicity of Marek' disease virus on evaluation of genetic resistance.

Authors:  K A Schat; B W Calnek; J Fabricant; H Abplanalp
Journal:  Poult Sci       Date:  1981-12       Impact factor: 3.352

Review 6.  Major histocompatibility (B) complex control of responses against Rous sarcomas.

Authors:  R L Taylor
Journal:  Poult Sci       Date:  2004-04       Impact factor: 3.352

7.  Resistance to a malignant lymphoma in chickens is mapped to subregion of major histocompatibility (B) complex.

Authors:  W E Briles; R W Briles; R E Taffs; H A Stone
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

8.  Influence of B-haplotype on the relative efficacy of Marek's disease vaccines of different serotypes.

Authors:  L D Bacon; R L Witter
Journal:  Avian Dis       Date:  1993 Jan-Mar       Impact factor: 1.577

9.  Ontogeny and line differences in the mitogenic response of chicken lymphocytes.

Authors:  L F Lee; L D Bacon
Journal:  Poult Sci       Date:  1983-04       Impact factor: 3.352

10.  Assignment of Rfp-Y to the chicken major histocompatibility complex/NOR microchromosome and evidence for high-frequency recombination associated with the nucleolar organizer region.

Authors:  M M Miller; R M Goto; R L Taylor; R Zoorob; C Auffray; R W Briles; W E Briles; S E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

View more
  22 in total

1.  Extended sequence of the turkey MHC B-locus and sequence variation in the highly polymorphic B-G loci.

Authors:  Miranda M Bauer; Kent M Reed
Journal:  Immunogenetics       Date:  2011-01-05       Impact factor: 2.846

2.  Two class I genes of the chicken MHC have different functions: BF1 is recognized by NK cells while BF2 is recognized by CTLs.

Authors:  Taejoong Kim; Henry D Hunt; Mark S Parcells; Vicky van Santen; Sandra J Ewald
Journal:  Immunogenetics       Date:  2018-06-09       Impact factor: 2.846

3.  Targeted capture enrichment and sequencing identifies extensive nucleotide variation in the turkey MHC-B.

Authors:  Kent M Reed; Kristelle M Mendoza; Robert E Settlage
Journal:  Immunogenetics       Date:  2016-01-05       Impact factor: 2.846

4.  A Newly Recognized Pairing Mechanism of the α- and β-Chains of the Chicken Peptide-MHC Class II Complex.

Authors:  Lijie Zhang; Xiaoying Li; Lizhen Ma; Bing Zhang; Geng Meng; Chun Xia
Journal:  J Immunol       Date:  2020-02-07       Impact factor: 5.422

5.  Defining the turkey MHC: identification of expressed class I- and class IIB-like genes independent of the MHC-B.

Authors:  Kent M Reed; Miranda M Bauer; Melissa S Monson; Benjamin Benoit; Lee D Chaves; Thomas H O'Hare; Mary E Delany
Journal:  Immunogenetics       Date:  2011-06-28       Impact factor: 2.846

Review 6.  Comparative study of tumorigenesis and tumor immunity in invertebrates and nonmammalian vertebrates.

Authors:  Jacques Robert
Journal:  Dev Comp Immunol       Date:  2010-06-02       Impact factor: 3.636

7.  Diversity and evolution of the highly polymorphic tandem repeat LEI0258 in the chicken MHC-B region.

Authors:  Olympe Chazara; Chi-Sheng Chang; Nicolas Bruneau; Khalid Benabdeljelil; Jean-Claude Fotsa; Boniface B Kayang; N'Goran E Loukou; Richard Osei-Amponsah; Valentine Yapi-Gnaore; Issaka A K Youssao; Chih-Feng Chen; Marie-Hélène Pinard-van der Laan; Michèle Tixier-Boichard; Bertrand Bed'hom
Journal:  Immunogenetics       Date:  2013-03-26       Impact factor: 2.846

8.  Polymorphism of duck MHC class molecules.

Authors:  Lin Zhang; Dongmei Lin; Sen Yu; Junping Bai; Wanchun Jiang; Wenzheng Su; Yanyan Huang; Shaohua Yang; Jiaqiang Wu
Journal:  Immunogenetics       Date:  2018-09-05       Impact factor: 2.846

9.  Sequence of a complete chicken BG haplotype shows dynamic expansion and contraction of two gene lineages with particular expression patterns.

Authors:  Jan Salomonsen; John A Chattaway; Andrew C Y Chan; Aimée Parker; Samuel Huguet; Denise A Marston; Sally L Rogers; Zhiguang Wu; Adrian L Smith; Karen Staines; Colin Butter; Patricia Riegert; Olli Vainio; Line Nielsen; Bernd Kaspers; Darren K Griffin; Fengtang Yang; Rima Zoorob; Francois Guillemot; Charles Auffray; Stephan Beck; Karsten Skjødt; Jim Kaufman
Journal:  PLoS Genet       Date:  2014-06-05       Impact factor: 5.917

10.  A high-density SNP panel reveals extensive diversity, frequent recombination and multiple recombination hotspots within the chicken major histocompatibility complex B region between BG2 and CD1A1.

Authors:  Janet E Fulton; Amy M McCarron; Ashlee R Lund; Kara N Pinegar; Anna Wolc; Olympe Chazara; Bertrand Bed'Hom; Mark Berres; Marcia M Miller
Journal:  Genet Sel Evol       Date:  2016-01-07       Impact factor: 4.297

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.